These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6958215)
21. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia. Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876 [TBL] [Abstract][Full Text] [Related]
22. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin]. Bartmann K; Tarbuc R Infection; 1982; 10(6):361-70. PubMed ID: 6818153 [TBL] [Abstract][Full Text] [Related]
23. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. IV. N-formimidoyl thienamycin. Traub WH Chemotherapy; 1983; 29(2):121-7. PubMed ID: 6340990 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Verbist L; Verhaegen J Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844 [TBL] [Abstract][Full Text] [Related]
25. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis. Shanson DC; Tadayon M J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp. Livingston WK; Elliott AM; Cobbs CG Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975 [TBL] [Abstract][Full Text] [Related]
27. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics. Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247 [TBL] [Abstract][Full Text] [Related]
28. Antimicrobial therapy of experimental enterococcal endocarditis. Hook EW; Roberts RB; Sande MA Antimicrob Agents Chemother; 1975 Nov; 8(5):564-70. PubMed ID: 1211911 [TBL] [Abstract][Full Text] [Related]
29. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Bush LM; Calmon J; Cherney CL; Wendeler M; Pitsakis P; Poupard J; Levison ME; Johnson CC Ann Intern Med; 1989 Apr; 110(7):515-20. PubMed ID: 2923386 [TBL] [Abstract][Full Text] [Related]
30. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Kesado T; Hashizume T; Asahi Y Antimicrob Agents Chemother; 1980 Jun; 17(6):912-7. PubMed ID: 6931548 [TBL] [Abstract][Full Text] [Related]
31. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria]. Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142 [TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin. Owens WE; Finegold SM Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265 [TBL] [Abstract][Full Text] [Related]
34. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus. Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899 [TBL] [Abstract][Full Text] [Related]
35. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa. Michael PR; Alford RH; McGee ZA Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926 [TBL] [Abstract][Full Text] [Related]
36. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics. Martino P; Venditti M; Valente B; Brandimarte C; Serra P Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis. Thornsberry C; Baker CN; Facklam RR Antimicrob Agents Chemother; 1974 Mar; 5(3):228-33. PubMed ID: 4840433 [TBL] [Abstract][Full Text] [Related]